In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology, Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022

  • ID: 4400136
  • Report
  • Region: Global
  • 255 Pages
  • Markets and Markets
1 of 6
The in Vitro Toxicology Testing Market is Expected to Reach USD 8.74 Billion By 2022 from An Estimated USD 6.34 Billion in 2017, at a CAGR of 6.6%.

FEATURED COMPANIES

  • Catalent, Inc.
  • Eurofins Scientific Se
  • Ge Healthcare
  • Gentronix Limited
  • MB Research Laboratories
  • Merck Kgaa
  • MORE

“The global in vitro toxicology testing market is projected to grow at a CAGR of 6.6%.”
The in vitro toxicology testing market is expected to reach USD 8.74 billion by 2022 from an estimated USD 6.34 billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage. On the other hand, failure to establish intricacies of in vivo conditions through in vitro, lack of in vitro models to study complex endpoints, and a dearth of skilled professionals are the major factors restraining the growth of this market.

“The services segment is expected to grow at the highest CAGR during the forecast period.”
On the basis of product and services, the in vitro toxicology testing market is segmented into assays, services, and reagents and labware. The services segment is expected to witness the highest growth during the forecast period. The growth of this segment can be attributed to the growing preference towards contract research in vitro toxicology testing services owing to the cost benefits offered by CROs.

“Toxicogenomics to grow at the highest rate in the global in vitro toxicology testing market by technology”
Based on technology, the in vitro toxicology testing market is segmented into cell culture, high-throughput, cellular imaging, and toxicogenomics technologies. The toxicogenomics segment is expected to account for the highest CAGR in the global in the vitro toxicology testing market. Toxicogenomics is preferred to elucidate the changes in gene expression in response to toxic exposure and facilitates to identify toxicity pathways.

“The Ex vivo models segment is expected to grow at the highest CAGR during the forecast period.”
Based on method, the in vitro toxicology testing market is segmented into cellular assays, biochemical assays, and ex vivo models. Ex vivo models segment is expected to grow at the highest CAGR during the forecast period owing to the growing adoption of these methods in the cosmetics industry as it is an effective alternative to animal testing for the toxicity testing of cosmetics and household products.

“China to witness the highest growth during the forecast period (2017-2022)”
The US is expected to hold the largest share of the global in vitro toxicology testing market in 2017, while China is expected to witness the highest growth during 2017 to 2022. Growing R&D investments in the biopharmaceutical sector, coupled with the rising number of CROs in this country contribute to the growth of this market in China. Additionally, rising international pressure on Chinese cosmetics industry to ban animal testing is expected to further drive this market.

Break of primary participants was as mentioned below:

  • By Company Type – Tier 1–25%, Tier 2–35% and Tier 3–40%
  • By Designation – C-level–22%, Director Level–33%, Others–45%
  • By Region – North America–30%, Europe–40%, Asia Pacific–15%, RoW–15%

The major players in the global in vitro toxicology testing market include Cyprotex  (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding’s subsidiary, US), Eurofins Scientific SE (Luxembourg), GE Healthcare (US), Thermo Fisher Scientific (US), SGS SA (Switzerland), Promega Corporation (US), Merck KGaA (Germany), Charles River Laboratories, Inc. (US), and Lonza Group Ltd. (Switzerland), among others.

Research Coverage:

  • The report analyzes the in vitro toxicology testing market and aims at estimating the market size and future growth potential of this market based on various aspects such as product and service; toxicity endpoint and tests; technology; method; industry; and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
  • Reasons to Buy the Report
  • The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by key players in the global in vitro toxicology testing market. The report analyzes the global in vitro toxicology testing market by product and service; toxicity endpoint and tests; technology; method; industry; and region.
  • Product and Service Innovation: Detailed insights on upcoming trends and new product and service launches in the global in vitro toxicology testing market
  • Market Development: Comprehensive information about the lucrative emerging markets by product and service; toxicity endpoint and tests; technology; method; and industry.
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global in vitro toxicology testing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products in pipeline of leading players in the global market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Catalent, Inc.
  • Eurofins Scientific Se
  • Ge Healthcare
  • Gentronix Limited
  • MB Research Laboratories
  • Merck Kgaa
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Covered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Share Estimation
2.2.1 Secondary Data
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Global In Vitro Toxicology Testing Market Overview
4.2 Europe Market: By Technology & Country
4.3 Global Market: By Country/Region
4.4 Global Market: Geographic Mix
4.5 Global Market: Developing vs Developed Markets (USD Billion)

5 Industry Insights
5.1 Introduction
5.2 Supply Chain Analysis
5.3 Regulatory Committee Activities
5.3.1 Major Stakeholders
5.3.2 Key Influencers
5.4 Industry Trends
5.4.1 Increasing R&D Spending in the Pharmaceutical and Biotechnology Sector
5.4.2 New and Promising Technological Advancements A Key Area of Focus for Market Players

6 Market Overview
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Opposition to Animal Testing
6.2.1.2 New and Promising In Vitro Technologies
6.2.1.3 Increasing R&D Expenditure to Detect Toxicity at an Early Stage
6.2.2 Restraints
6.2.2.1 Reluctance of Regulatory Authorities to Consider Alternative Methods for Proving Safety and Efficacy
6.2.2.2 Failure to Establish Intricacies of In Vivo Conditions Through In Vitro
6.2.2.3 Lack of In Vitro Models to Study Complex Endpoints
6.2.3 Opportunities
6.2.3.1 Toxicology in the 21st Century (Tox21) Program
6.2.3.2 Increasing Drug Discovery and Innovation & Modernization in the In Vitro Toxicity Testing Market
6.2.3.3 Increasing Toxicology Databases Will Facilitate the Use of In Vitro Test Methods
6.2.4 Challenges
6.2.4.1 Dearth of Skilled Professionals

7 In Vitro Toxicology Testing Market, By Product and Service
7.1 Introduction
7.2 Assays
7.2.1 Bacterial Toxicity Assays
7.2.2 Enzyme Toxicity Assays
7.2.3 Cell-Based Elisa and Western Blots
7.2.4 Receptor-Binding Assays
7.2.5 Tissue Culture Assays
7.2.6 Other Assays
7.3 Services
7.4 Reagents & Labware

8 In Vitro Toxicology Testing Market, By Toxicity Endpoints and Tests
8.1 Introduction
8.1.1 ADME (Absorption, Distribution, Metabolism, and Excretion)
8.1.2 Skin Irritation, Corrosion, and Sensitization
8.1.3 Genotoxicity Testing
8.1.4 Cytotoxicity Testing
8.1.5 Ocular Toxicity
8.1.6 Organ Toxicity
8.1.7 Phototoxicity Testing
8.1.8 Dermal Toxicity
8.1.9 Carcinogenicity
8.1.10 Neurotoxicity
8.1.11 Other Toxicity Endpoints & Tests

9 In Vitro Toxicology Testing Market, By Technology
9.1 Introduction
9.2 Cell Culture Technologies
9.3 High-Throughput Technologies
9.4 Cellular Imaging Technologies
9.5 Toxicogenomics

10 In Vitro Toxicology Testing Market, By Industry
10.1 Introduction
10.2 Pharmaceutical and Biopharmaceutical Industry
10.3 Cosmetics and Household Products Industry
10.4 Food Industry
10.5 Chemical Industry

11 In Vitro Toxicology Testing Market, By Method
11.1 Introduction
11.2 Cellular Assays
11.3 Biochemical Assays
11.4 EX Vivo Models

12 In Vitro Toxicology Testing Market, By Region
12.1 Introduction
12.2 Europe
12.2.1 Germany
12.2.2 UK
12.2.3 France
12.2.4 Italy
12.2.5 Spain
12.2.6 Rest of Europe (RoE)
12.3 North America
12.3.1 US
12.3.2 Canada
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Rest of Asia Pacific (RoAPAC)
12.5 Rest of the World (RoW)

13 Competitive Landscape
13.1 Overview
13.2 Market Ranking Analysis

14 Company Profiles
14.1 SGS S.A.
14.2 Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
14.3 Bio-Rad Laboratories, Inc.
14.4 Qiagen N.V.
14.5 GE Healthcare
14.6 Eurofins Scientific SE
14.7 Merck KGaA
14.8 Thermo Fisher Scientific, Inc
14.9 Charles River Laboratories International, Inc.
14.10 Catalent, Inc.
14.11 Cyprotex PLC (A Subsidiary of Evotec AG)
14.12 Promega Corporation
14.13 Gentronix Limited
14.14 Ascendance Biotechnology, Inc.
14.15 MB Research Laboratories

15 Appendix
15.1 Insights of Industry Experts
15.2 Discussion Guide
15.3 Knowledge Store: Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Related Reports
15.6 Author Details

List of Tables (139 Tables)

Table 1 In Vitro Toxicology Testing Market, By Product and Service, 2015–2022 (USD Million)
Table 2 Market for Assays, By Type, 2015–2022 (USD Million)
Table 3 Market for Assays, By Country/Region, 2015–2022 (USD Million)
Table 4 Market for Bacterial Toxicity Assays, By Country/Region, 2015–2022 (USD Million)
Table 5 In Vitro Toxicity Testing Market for Enzyme Toxicity Assays, By Country/Region, 2015–2022 (USD Million)
Table 6 Market for Cell-Based Elisa and Western Blots, By Country/Region, 2015–2022 (USD Million)
Table 7 Market for Receptor-Binding Assays, By Country/Region, 2015–2022 (USD Million)
Table 8 In Vitro Toxicology Testing Market for Tissue Culture Assays, By Country/Region, 2015–2022 (USD Million)
Table 9 Market for Other Assays, By Country/Region, 2015–2022 (USD Million)
Table 10 Market for Services, By Country/Region, 2015–2022 (USD Million)
Table 11 Market for Reagents & Labware, By Country/Region, 2015–2022 (USD Million)
Table 12 In Vitro Toxicity Testing Market, By Toxicity Endpoint and Test, 2015–2022 (USD Million)
Table 13 In Vitro Toxicity Testing Market for ADME, By Country/Region, 2015–2022 (USD Million)
Table 14 In Vitro Toxicity Testing Market for Skin Irritation, Corrosion, and Sensitization, By Country/Region, 2015–2022 (USD Million)
Table 15 In Vitro Toxicity Testing Market for Genotoxicity Testing, By Country/Region, 2015–2022 (USD Million)
Table 16 In Vitro Toxicity Testing Market for Cytotoxicity Testing, By Country/Region, 2015–2022 (USD Million)
Table 17 In Vitro Toxicity Testing Market for Ocular Toxicity, By Country/Region, 2015–2022 (USD Million)
Table 18 In Vitro Toxicity Testing Market for Organ Toxicity, By Country/Region, 2015–2022 (USD Million)
Table 19 In Vitro Toxicity Testing Market for Phototoxicity Testing, By Country/Region, 2015–2022 (USD Million)
Table 20 In Vitro Toxicity Testing Market for Dermal Toxicity, By Country/Region, 2015–2022 (USD Million)
Table 21 In Vitro Toxicity Testing Market for Carcinogenicity, By Country/Region, 2015–2022 (USD Million)
Table 22 In Vitro Toxicity Testing Market for Neurotoxicity, By Country/Region, 2015–2022 (USD Million)
Table 23 In Vitro Toxicity Testing Market for Other Toxicity Endpoint & Test, By Country/Region, 2015–2022 (USD Million)
Table 24 In Vitro Toxicology Testing Market, By Technology, 2015–2022 (USD Million)
Table 25 Market for Cell Culture Technologies, By Country/Region, 2015–2022 (USD Million)
Table 26 Market for High-Throughput Technologies, By Country/Region, 2015–2022 (USD Million)
Table 27 Market for Cellular Imaging Technologies, By Country/Region, 2015–2022 (USD Million)
Table 28 Market for Toxicogenomics, By Country/Region, 2015–2022 (USD Million)
Table 29 Market, By Industry, 2015–2022 (USD Million)
Table 30 In Vitro Toxicology Testing Market for Pharmaceuticals and Biopharmaceuticals Industry, By Country/Region, 2015–2022 (USD Million)
Table 31 Market for Cosmetics & Household Products Industry, By Country/Region, 2015–2022 (USD Million)
Table 32 Market for the Food Industry, By Country/Region, 2015–2022 (USD Million)
Table 33 Market Size for the Chemical Industry, By Country/Region, 2015–2022 (USD Million)
Table 34 Market, By Method, 2015–2022 (USD Million)
Table 35 Market for Cellular Assays, By Country/Region, 2015–2022 (USD Million)
Table 36 In Vitro Toxicology Testing Market for Biochemical Assays, By Country/Region, 2015–2022 (USD Million)
Table 37 Market for Ex Vivo Assays, By Country/Region, 2015–2022 (USD Million)
Table 38 Market, By Region, 2015–2022 (USD Million)
Table 39 Market, By Country/Region, 2015–2022 (USD Million)
Table 40 Europe: In Vitro Toxicology Testing Market, By Country/Region, 2015–2022 (USD Million)
Table 41 Europe: Market, By Product and Service, 2015–2022(USD Million)
Table 42 Europe: Market for Assays, By Type, 2015–2022 (USD Million)
Table 43 Europe: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 44 Europe: Market, By Technology, 2015–2022 (USD Million)
Table 45 Europe: Market, By Method, 2015–2022 (USD Million)
Table 46 Europe: Market, By Industry, 2015–2022 (USD Million)
Table 47 Germany: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 48 Germany: Market for Assays, By Type, 2015–2022 (USD Million)
Table 49 Germany: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 50 Germany: Market, By Technology, 2015–2022 (USD Million)
Table 51 Germany: Market, By Method, 2015–2022 (USD Million)
Table 52 Germany: Market, By Industry, 2015–2022 (USD Million)
Table 53 UK: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 54 UK: Market for Assays, By Type, 2015–2022 (USD Million)
Table 55 UK: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 56 UK: Market, By Technology, 2015–2022 (USD Million)
Table 57 UK: Market, By Method, 2015–2022 (USD Million)
Table 58 UK: Market, By Industry, 2015–2022 (USD Million)
Table 59 France: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022 (USD Million)
Table 60 France: Market for Assays, By Type, 2015–2022 (USD Million)
Table 61 France: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 62 France: Market, By Technology, 2015–2022 (USD Million)
Table 63 France: Market, By Method, 2015–2022 (USD Million)
Table 64 France: Market, By Industry, 2015–2022 (USD Million)
Table 65 Italy: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022 (USD Million)
Table 66 Italy: Market for Assays, By Type, 2015–2022 (USD Million)
Table 67 Italy: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 68 Italy: Market, By Technology, 2015–2022 (USD Million)
Table 69 Italy: Market, By Method, 2015–2022 (USD Million)
Table 70 Italy: Market, By Industry, 2015–2022 (USD Million)
Table 71 Spain: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 72 Spain: Market for Assays, By Type, 2015–2022 (USD Million)
Table 73 Spain: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 74 Spain: Market, By Technology, 2015–2022 (USD Million)
Table 75 Spain: Market, By Method, 2015–2022 (USD Million)
Table 76 Spain: Market, By Industry, 2015–2022 (USD Million)
Table 77 RoE: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 78 RoE: Market for Assays, By Type, 2015–2022 (USD Million)
Table 79 RoE: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 80 RoE: Market, By Technology, 2015–2022 (USD Million)
Table 81 RoE: Market, By Method, 2015–2022 (USD Million)
Table 82 RoE: Market, By Industry, 2015–2022 (USD Million)
Table 83 North America: In Vitro Toxicology Testing Market, By Country/Region, 2015–2022 (USD Million)
Table 84 North America: Market, By Product and Service, 2015–2022(USD Million)
Table 85 North America: Market for Assays, By Type, 2015–2022 (USD Million)
Table 86 North America: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 87 North America: Market, By Technology, 2015–2022 (USD Million)
Table 88 North America: Market, By Method, 2015–2022 (USD Million)
Table 89 North America: Market, By Industry, 2015–2022 (USD Million)
Table 90 US: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 91 US: Market for Assays, By Type, 2015–2022 (USD Million)
Table 92 US: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 93 US: Market, By Technology, 2015–2022 (USD Million)
Table 94 US: Market, By Method, 2015–2022 (USD Million)
Table 95 US: Market, By Industry, 2015–2022 (USD Million)
Table 96 Canada: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 97 Canada: Market for Assays, By Type, 2015–2022 (USD Million)
Table 98 Canada: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 99 Canada: Market, By Technology, 2015–2022 (USD Million)
Table 100 Canada: Market, By Method, 2015–2022 (USD Million)
Table 101 Canada: Market, By Industry, 2015–2022 (USD Million)
Table 102 APAC: In Vitro Toxicology Testing Market, By Country/Region, 2015–2022 (USD Million)
Table 103 APAC: Market, By Product and Service, 2015–2022(USD Million)
Table 104 APAC: Market for Assays, By Type, 2015–2022 (USD Million)
Table 105 APAC: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 106 APAC: Market, By Technology, 2015–2022 (USD Million)
Table 107 APAC: Market, By Method, 2015–2022 (USD Million)
Table 108 APAC: Market, By Industry, 2015–2022 (USD Million)
Table 109 Japan: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 110 Japan: Market for Assays, By Type, 2015–2022 (USD Million)
Table 111 Japan: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 112 Japan: Market, By Technology, 2015–2022 (USD Million)
Table 113 Japan: Market, By Method, 2015–2022 (USD Million)
Table 114 Japan: Market, By Industry, 2015–2022 (USD Million)
Table 115 China: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 116 China: Market for Assays, By Type, 2015–2022 (USD Million)
Table 117 China: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 118 China: Market, By Technology, 2015–2022 (USD Million)
Table 119 China: Market, By Method, 2015–2022 (USD Million)
Table 120 China: Market, By Industry, 2015–2022 (USD Million)
Table 121 India: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 122 India: Market for Assays, By Type, 2015–2022 (USD Million)
Table 123 India: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 124 India: Market, By Technology, 2015–2022 (USD Million)
Table 125 India: Market, By Method, 2015–2022 (USD Million)
Table 126 India: Market, By Industry, 2015–2022 (USD Million)
Table 127 RoAPAC: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 128 RoAPAC: Market for Assays, By Type, 2015–2022 (USD Million)
Table 129 RoAPAC: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 130 RoAPAC: Market, By Technology, 2015–2022 (USD Million)
Table 131 RoAPAC: Market, By Method, 2015–2022 (USD Million)
Table 132 RoAPAC: Market, By Industry, 2015–2022 (USD Million)
Table 133 RoW: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 134 RoW: Market for Assays, By Type, 2015–2022 (USD Million)
Table 135 RoW: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 136 RoW: Market, By Technology, 2015–2022 (USD Million)
Table 137 RoW: Market, By Method, 2015–2022 (USD Million)
Table 138 RoW: Market, By Industry, 2015–2022 (USD Million)
Table 139 Rank of Companies in the In Vitro Toxicology Testing Market, 2016

List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 In Vitro Toxicology Testing Market, By Product and Service, 2017 vs 2022 (USD Billion)
Figure 7 Market, By Toxicity Endpoint & Test, 2017 vs 2022 (USD Million)
Figure 8 Global Market, By Technology, 2017 vs 2022 (USD Billion)
Figure 9 Market, By Method, 2017 vs 2022 (USD Billion)
Figure 10 In Vitro Toxicology Testing Market, By Industry, 2017 vs 2022 (USD Billion)
Figure 11 Geographical Snapshot of the Global Market, 2017
Figure 12 Opposition to Animal Testing and Increase in R&D Spending to Drive Market Growth
Figure 13 Toxicogenomics Technologies is Expected to Command the Largest Market Share in 2017
Figure 14 China to Register Highest Growth During the Forecast Period
Figure 15 Europe Holds the Highest Market Share During the Forecast Period
Figure 16 Developing Markets to Grow at the Highest CAGRs From 2017 to 2022
Figure 17 Supply Chain Analysis: In Vitro Toxicology Testing Market (As of 2016)
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Global Market Snapshot (2017)
Figure 20 Europe: Market Snapshot, 2017 (USD Million)
Figure 21 Asia Pacific: In Vitro Toxicology Testing Market Snapshot (2017)
Figure 22 SGS S.A.: Company Snapshot (2016)
Figure 23 Laboratory Corporation of America Holdings: Company Snapshot (2016)
Figure 24 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 25 Qiagen N.V.: Company Snapshot (2016)
Figure 26 GE Healthcare: Company Snapshot (2016)
Figure 27 Eurofins Scientific Se: Company Snapshot (2016)
Figure 28 Merck KGaA: Company Snapshot (2016)
Figure 29 Thermo Fisher Scientific, Inc.: Company Snapshot (2016)
Figure 30 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 31 Catalent, Inc.: Company Snapshot (2016)
Figure 32 Evotec AG: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Ascendance Biotechnology, Inc.
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
  • Cyprotex Plc (A Subsidiary of Evotec Ag)
  • Eurofins Scientific Se
  • Ge Healthcare
  • Gentronix Limited
  • MB Research Laboratories
  • Merck Kgaa
  • Promega Corporation
  • Qiagen N.V.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll